Keros Therapeutics (KROS) Q4 2025 Earnings

Nov 5Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.36
0.3
1.96
3.62

Details

Expected EPS
-1.135089
Actual EPS
-0.18
Surprise EPS
0.96
Surprise Percent
+84.14%

Description

⁨Keros Therapeutics⁩ (⁦KROS⁩) has reported earnings of ⁦-0.18⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts